drugset / Trial / NCT03237442
Umbilical Cord Mesenchymal Stem Cells Injection for Ocular Corneal Burn
RandomizedParallel-groupDouble-blindTreatment
Summary
Ocular chemical burn is one of the causes of vision loss in China, and there are no satisfactory treatment. Human umbilical cord mesenchymal stem cells(UC-MSCs) have the biological characteristics of self-renewal, immune regulation, multidirectional differentiation and tissue repair. Our preliminary research showed that in corneal alkali injury rabbits, the UC-MSCs can accelerated the cornea repair, inhibited angiogenesis. The aim of this study is to access the efficacy and safety of UC-MSCs in the treatment of corneal burn in human.
Timeline
- Start
- 2018-01-01
- Primary completion
- 2018-12-30
- Completion
- 2019-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 0.2 ml | Other |
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 2e+06 cells | Other |